Identification of complement inhibitors and complement regulatory proteins in ABO-incompatible compare with HLA-incompatible kidney transplantation

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20210904002

Enrollment

Registered

2021-09-04

Start date

2021-10-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ABOi kidney transplantation HLAi kidney transplantation Accommodation ABO incompatibility or ABO incompatible kidney transplantation Complement regulatory proteins Complement inhibitors HLA incompatibility or HLA incompatible kidney transplantation Kidney transplantation

Interventions

ABO incompatible KT,HLA incompatible KT,ABO/HLA compatible KT

Basic Science,Basic Science,Basic Science

ABOi KT,HLAi KT ,ABO/HLA compatible KT

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Transplantation patients in King Chulalongkorn Memorial Hospital 2. Patients who ever had kidney biopsy

Exclusion criteria

Exclusion criteria: 1. Contraindication for kidney biopsy 2. Recurrent glomerular disease 3. Urinary tract infection

Design outcomes

Primary

Measure	Time frame
Complement inhibitors 12 months PCR	—

Secondary

Measure	Time frame
Complement regulatory proteins 12 months PCR	—

Countries

Thailand

Contacts

Public ContactKavita Jintanapramote

King Chulalongkorn Memorial Hospital

kavita.jint@gmail.com022564000

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026